Concepedia

Min Gao

MG

Statistics

Publications

33

Citations

3.3K

H-Index

19

Active since

1995

Affiliations

Bristol-Myers Squibb (United States)(Current)

Shandong Tumor Hospital

Shandong First Medical University

Huzhou Central Hospital

Huzhou University

Min Gao is an author at Bristol-Myers Squibb (United States) specializing in molecular virology, antiviral pharmacology, and virology.

Publications per year

1995–2024

33

Publications

33

Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection

Mark Sulkowski, David Gardiner, M. Rodríguez‐Torres et al. · New England Journal of Medicine · 2014 · 1.2K citations

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect

Min Gao, Richard E. Nettles, Makonen Belema et al. · Nature · 2010 · 937 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Identification of Hepatitis C Virus NS5A Inhibitors

Julie A. Lemm, Donald R. O’Boyle, Mengping Liu et al. · Journal of Virology · 2009 · 194 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

Multiple ascending dose study of BMS-790052, a nonstructural protein 5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1

Richard E. Nettles, Min Gao, Marc Bifano et al. · Hepatology · 2010 · 177 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Inhibitors of HCV NS5A: From Iminothiazolidinones to Symmetrical Stilbenes

J. Romine, Denis R. St. Laurent, John E. Leet et al. · ACS Medicinal Chemistry Letters · 2011 · 86 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

1–5 of 33